Renal Impairment in Patients With Acute Heart Failure: Are Inotropes Safe?
J Cardiovasc Pharmacol
.
2022 Jun 1;79(6):772-773.
doi: 10.1097/FJC.0000000000001269.
Authors
Piero Pollesello
1
,
Matti Kivikko
1
2
Affiliations
1
Medical Advisory and Scientific Communication Functions, Medical Affairs, R&D, Orion Pharma, Espoo, Finland; and.
2
Department of Cardiology, Jorvi Hospital, Espoo, Finland.
PMID:
35383633
DOI:
10.1097/FJC.0000000000001269
No abstract available
Publication types
Comment
MeSH terms
Acute Disease
Cardiotonic Agents / adverse effects
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Renal Insufficiency*
Substances
Cardiotonic Agents